SCHEMBL4604853

SCHEMBL4604853

CC(=O)C(C(C)=O)=P(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
USP2 O75604 1/20 0.40
ESR1 P03372 1/20 0.40
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CFTR P13569 1/20 0.38
NAPRT Q6XQN6 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3995747 0.81 CES2 (0.44) CES2CES1CA2CA4CA5A
SCHEMBL10322782 0.80 KMT2A (0.47) KMT2APOLBNPSR1MAPTSMN1; SMN2
SCHEMBL7929097 0.77 CES2 (0.41) CES2CES1CA2CA4CA5A
SCHEMBL67922 0.76 CA2 (0.42) CES2CES1CA2CA4CA5A
SCHEMBL10999121 0.76 CES1 (0.50) CES2CES1CA2CA4CA5A
SCHEMBL5072367 0.74 CES2 (0.56) CES2CES1CA2CA4CA5A
SCHEMBL5568513 0.74 CA2 (0.43) CES2CES1CA2CA4CA5A
SCHEMBL4764636 0.73 MAPT (0.40) CES2CES1CA2CA4CA5A
SCHEMBL25650566 0.73 KMT2A (0.49) CES2CES1CA2CA4CA5A
SCHEMBL10962127 0.73 CES2 (0.38) CES2CES1CA2CA4CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269857-B Curable resin composition, dry film and cured product thereof, and electronic component comprising the cured product 太阳控股株式会社 2025-02-25 CN disclosed
CN-114269857-A Curable resin composition, dry film and cured product thereof, and electronic component comprising cured product 太阳油墨制造株式会社 2022-04-01 CN disclosed
WO-2021045085-A1 CURABLE RESIN COMPOSITION, DRY FILM AND CURED PRODUCT OF SAME, AND ELECTRONIC COMPONENT CONTAINING SAID CURED PRODUCT 太陽インキ製造株式会社 2021-03-11 WO disclosed
CN-1818779-B Photosensitive resin composition, its condensate and display panel used interval element formed therewith TAIYO INK MFG CO LTD 2011-02-02 CN disclosed
CN-100454142-C Photocurable and thermosetting resin composition, photosensitive dry film thereof, and pattern forming method using same UNIV KANAGAWA (JP) 2009-01-21 CN disclosed
EP-1341039-B1 PHOTOCURABLE AND THERMOSETTING RESIN COMPOSITION UNIV KANAGAWA (JP) 2008-07-09 EP disclosed
US-7238763-B2 Unsaturated monocarboxylic ester compounds KANAGAWA UNIVERSITY AND TAIYO INK MANUFACTURING CO., LTD. (JP) 2007-07-03 US disclosed
US-7226710-B2 Photocurable/therosetting resin composition, photosensitive dry film formed therefrom and method of forming pattern with the same KANAGAWA UNIVERSITY (JP) 2007-06-05 US disclosed
US-7208568-B2 Resin curable with actinic radiation, process for the production thereof, and photocurable and thermosetting resin composition KANAGAWA UNIVERSITY (JP) 2007-04-24 US disclosed
EP-1251118-B1 UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY UNIV KANAGAWA (JP) 2006-12-20 EP disclosed
US-20040039087-A1 Unsaturated polyester compounds, resins curable with actinic energy ray, processes for the production thereof, and curable compositions KANAGAWA UNIVERSITY (JP) 2004-02-26 US disclosed
US-20040023120-A1 Photocurable/thermosetting resin composition, photosensitive dry film formed therefrom, and method of forming pattern with the same TAIYO INK MANUFACTURING CO., LTD. (JP) 2004-02-05 US disclosed
US-20030216514-A1 Photocurable and thermosetting resin composition TAIYO INK MANUFACTURING CO., LTD. (JP) 2003-11-20 US disclosed
EP-1341039-A1 PHOTOCURABLE AND THERMOSETTING RESIN COMPOSITION Kanagawa University (JP) 2003-09-03 EP disclosed
US-20030153723-A1 Resins curable with actinic energy ray, process for the production thereof, and photocurable and thermosetting resin composition KANAGAWA UNIVERSITY (JP) 2003-08-14 US disclosed
CN-1420998-A Photocurable/thermosetting resin composition, photosensitive dry film thereof, and pattern forming method using same UNIV KANAGAWA (JP) 2003-05-28 CN disclosed
EP-1275665-A1 RESINS CURABLE WITH ACTINIC RADIATION, PROCESS FOR THE PRODUCTION THEREOF, AND PHOTO- AND THERMO-SETTING RESIN COMPOSITION Kanagawa University (JP) 2003-01-15 EP disclosed
EP-1276011-A1 PHOTOCURABLE/THERMOSETTING RESIN COMPOSITION, PHOTOSENSITIVE DRY FILM FORMED THEREFROM, AND METHOD OF FORMING PATTERN WITH THE SAME Kanagawa University (JP) 2003-01-15 EP disclosed
US-20030009053-A1 Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray KANAGAWA UNIVERSITY (JP) 2003-01-09 US disclosed
EP-1251118-A1 UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY Kanagawa University (JP) 2002-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030009053-A1 Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray ACSL1, ACSL6, ACSL4 CES2 256/4885CES1 433/4885CA2 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.